Nomura Holdings (NMR) Beats Q1 2027 EPS by 27% on Trading Surge

As seen on the 24/7 Wall St. homepage on July 29, 2026.

NMR Nomura Holdings
Q1 2027
EPS
$0.30
est $0.22 +27.5%
Revenue
$4.20B
est $583.00B -99.3%

Nomura crushed Q1 expectations with $0.30 EPS, blowing past the $0.23 estimate as wholesale trading gains and investment management fees surged. The Japanese investment bank's net revenue climbed 31.2% year over year, with wholesale pre-tax income more than doubling and the firm now targeting a 10-12% ROE by 2030.

Continue ReadingShow less

Nomura reported Q1 2027 earnings per share of $0.30, clearing the $0.23 consensus estimate by roughly 27%. The headline driver was strength across wholesale trading and investment management fees, both of which pushed net revenue 31.2% higher compared with the same quarter a year ago. Wholesale pre-tax income more than doubled, making it the standout segment of the quarter.

The beat extends a mixed recent track record for the Japanese investment bank. Nomura missed estimates in three of the prior four quarters — Q3 2026, Q4 2026, and Q1 2026 — so the scale of this outperformance marks a meaningful shift in momentum. Management has set a return-on-equity target of 10–12% by 2030, and a quarter like this, where multiple business lines fired at once, is the kind of result that lends credibility to that goal.

Sponsored

Are You Ready To Retire, Or Years Behind?

Most Americans suspect they're behind on retirement and never find out. Advisor.com's free matching tool pairs you in about three minutes with a vetted fiduciary advisor who can help you with investing, taxes, retirement, estate planning, and more. No minimums. No sales call. Find out where you stand.

One figure to treat with caution is the revenue beat percentage shown in some data feeds. The reported net revenue of roughly $4.2 billion compares against an estimated figure that appears to reflect a data anomaly rather than actual analyst consensus, so investors should focus on the 31.2% year-over-year revenue growth and the EPS beat as the more reliable measures of Nomura's quarterly performance.

Mentioned: NMR, NRSCF